(Q41507880)

1 October 2017

1 reference

title

Hormone replacement therapy and other potential treatments for dementias (English)

1 reference

Hormone Replacement Therapy

1 October 2017

main subject

1 reference

4

Shumaker SA

1 reference

1 October 2017

McBee WL

1

1 reference

1 October 2017

Dailey ME

series ordinal

2

1 reference

1 October 2017

Dugan E

series ordinal

3

1 reference

1 October 2017

publication date

1 June 1997

1 reference

Endocrinology and Metabolism Clinics of North America

1 October 2017

published in

1 reference

1 October 2017

volume

26

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

329-345

1 reference

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Women, myocardial infarction, and dementia in the very old.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogen replacement therapy and cognitive function in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Rheumatoid arthritis and susceptibility to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Low Body Mass Index in demented outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

1 reference

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

A case-control study of Alzheimer's disease in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Aphasia in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

The role of free radicals in disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

1 reference

7 January 2021

Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

A case-control study of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Relative Rates of Dementia By Multiple Case Definitions, Over Two Prevalence Periods, In Three Sociocultural Groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Sex differences in postischemic neuronal necrosis in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Senile dementia-Alzheimer's type and estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

The prevalence of dementia: a quantitative integration of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Epidemiology of multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Education and the prevalence of dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

A case-control study of Alzheimer's disease in China

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Neuroimmune mechanisms in Alzheimer disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Alzheimer's disease and rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Down's syndrome: prophylaxis and therapy for the frequently comorbid Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Effects of estrogen on memory function in surgically menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogen replacement therapy and memory in older women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

More evidence links NSAID, estrogen use with reduced Alzheimer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Influence of education and occupation on the incidence of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Mechanisms of estrogen action during neural development: mediation by interactions with the neurotrophins and their receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970250-4

7 January 2021

10.1016/S0889-8529(05)70250-4

Identifiers

DOI

1 reference

1 October 2017

1 reference